Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FBTK9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,842
Award facts
- Contract value 100% obligated
- $17,842.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,842.38 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pens on January 20, 2026, with an ultimate completion date of January 21, 2026. This non-set-aside contract uses firm fixed-price pricing and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2031 that enables the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical vendor for federal medical procurement serving military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to compete on a full and open basis for diverse pharmaceutical products across multiple therapeutic domains. This delivery order for Zepbound, a GLP-1 receptor agonist medication used in diabetes and weight management treatment, reflects the company's ongoing role in supplying specialized pharmaceutical commodities to Defense Health Agency and other government healthcare systems through its established prime vendor relationship with the DLA.
Quick answers
Who was awarded contract SPE2DR26FBTK9?
SPE2DR26FBTK9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FBTK9 worth?
The government has obligated $17,842 on SPE2DR26FBTK9.
Is contract SPE2DR26FBTK9 an order under another contract?
Yes. SPE2DR26FBTK9 is a delivery order under SPE2DR25D2002, an indefinite delivery contract.
Was contract SPE2DR26FBTK9 competed?
The extent of competition for SPE2DR26FBTK9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award